Research programme: RNA immunotherapeutics - Epitopea
Latest Information Update: 18 Aug 2024
Price :
$50 *
At a glance
- Originator Epitopea
- Class Antineoplastics; Cancer vaccines; Immunotherapies; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer